• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue2

Synthesis Of Pyrazolopyrimidine Derivatives Along With Its Biological Activity Including Toxicity Studies

    S. Singh Dr. Mohammad. Gousuddin Huma Khan

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 2, Pages 182-200

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Pyrazolopyrimidines and related fused heterocycles are of interest as potential bioactive molecules. The heterocyclic fusion of pyrimidine ring and pyrazole ring resulted in formation of pyrazolopyrimidines, the structural analogues of biogenic purine class, undoubtedly, has high significance in the field of pharmaceutical and biotechnological sciences with wide spectrum of biological activities and its several derivatives. Toxicity may be due to the accumulation in a specific organ/ tissue (e.g. bosentan), the co -administration of other drugs affecting ADMET (absorption, distribution, metabolism, elimination and toxicity) Cmax reaching off target IC50, or the high Cmax required for therapeutic effects. Assessing the relative drug efficacy and toxicity is important for medicinal chemists, pharmacologists, pharmacists, physicians. As multiple treatment options are available for many diseases, relative toxicity assessment is necessary. Difficulty in direct clinical trial comparisons forces network meta-analyses for estimating the relative toxicity. Therapeutic index (TI) assumes simplified linear relationships between receptor affinity, maximum unbound plasma drug concentration (Cmax) and toxicity. But high TI does not guarantee safety. For drugs metabolized by cytochrome P450 (CYP450),estimating TI based on target potencies alone is insufficient.
Keywords:
    Anti-inflammatory activity Analgesic activity In Silico toxicity
  • PDF (637 K)
  • XML
(2021). Synthesis Of Pyrazolopyrimidine Derivatives Along With Its Biological Activity Including Toxicity Studies. European Journal of Molecular & Clinical Medicine, 8(2), 182-200.
S. Singh; Dr. Mohammad. Gousuddin; Huma Khan. "Synthesis Of Pyrazolopyrimidine Derivatives Along With Its Biological Activity Including Toxicity Studies". European Journal of Molecular & Clinical Medicine, 8, 2, 2021, 182-200.
(2021). 'Synthesis Of Pyrazolopyrimidine Derivatives Along With Its Biological Activity Including Toxicity Studies', European Journal of Molecular & Clinical Medicine, 8(2), pp. 182-200.
Synthesis Of Pyrazolopyrimidine Derivatives Along With Its Biological Activity Including Toxicity Studies. European Journal of Molecular & Clinical Medicine, 2021; 8(2): 182-200.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 344
  • PDF Download: 561
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus